Technical Analysis for SBPH - Spring Bank Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 6.53 -2.97% -0.20
SBPH closed down 2.97 percent on Friday, May 24, 2019, on 49 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SBPH trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -2.97%
180 Bearish Setup Bearish Swing Setup -2.97%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.97%
Inside Day Range Contraction -2.97%
Crossed Above 20 DMA Bullish -8.93%
Fell Below 20 DMA Bearish -1.80%
Outside Day Range Expansion -1.80%
20 DMA Support Bullish -6.04%
NR7 Range Contraction -6.04%

Older signals for SBPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of a class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its SMNH compounds are small segments of nucleic acids that are design to target and modulate the activity of specific proteins implicated in various disease states. The company's lead product candidate is SB 9200, which completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus and respiratory syncytial virus. It also develops preclinical product candidates, such as SB 9400, SB 9941 and SB 9946 for RNA viral diseases. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Milford, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Disease Specialty Drugs Chronic Hepatitis B Virus Human Orthopneumovirus Preclinical Preclinical Product
Is SBPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.0
52 Week Low 6.3
Average Volume 49,835
200-Day Moving Average 10.5978
50-Day Moving Average 8.4266
20-Day Moving Average 6.9523
10-Day Moving Average 6.944
Average True Range 0.6135
ADX 16.75
+DI 12.6757
-DI 17.4958
Chandelier Exit (Long, 3 ATRs ) 6.1395
Chandelier Exit (Short, 3 ATRs ) 8.1505
Upper Bollinger Band 7.3945
Lower Bollinger Band 6.5101
Percent B (%b) 0.02
BandWidth 12.72097
MACD Line -0.4007
MACD Signal Line -0.4767
MACD Histogram 0.076
Fundamentals Value
Market Cap 82.91 Million
Num Shares 12.7 Million
EPS -2.50
Price-to-Earnings (P/E) Ratio -2.61
Price-to-Sales 0.00
Price-to-Book 4.56
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.31
Resistance 3 (R3) 7.33 7.10 7.18
Resistance 2 (R2) 7.10 6.90 7.09 7.14
Resistance 1 (R1) 6.81 6.78 6.70 6.79 7.09
Pivot Point 6.58 6.58 6.52 6.57 6.58
Support 1 (S1) 6.29 6.38 6.18 6.27 5.97
Support 2 (S2) 6.06 6.26 6.05 5.92
Support 3 (S3) 5.77 6.06 5.88
Support 4 (S4) 5.75